ASH News Daily 2013 - Day 3 - (Page A-3)

Building Pathways of Possibility For more than 25 years, Gilead Sciences has been committed to developing medicines that address areas of unmet medical need for patients worldwide. We are now advancing a pipeline of novel therapies for a range of cancers, including agents that target key intracellular signaling pathways and the extracellular matrix involved in the growth and survival of certain cancers, for which existing treatment options are limited. Visit us at our ASH Booth 3428 to learn more about Gilead's pipeline in oncology. For more information on Gilead Sciences, visit www.gilead.com. ©2013 Gilead Sciences, Inc. All rights reserved. UNBP0397 76581ha_a.indd 1 11/13/13 9:54 PM

Table of Contents for the Digital Edition of ASH News Daily 2013 - Day 3

Table of Contents

ASH News Daily 2013 - Day 3

https://www.nxtbookmedia.com